| USD ($) $ in Millions | Jul 25, 2026 | Jul 26, 2025 | Jul 27, 2024 | Jul 29, 2023 | Jul 30, 2022 | Jul 31, 2021 | Jul 25, 2020 | Jul 27, 2019 | Jul 28, 2018 | Jul 29, 2017 | Jul 30, 2016 | Jul 25, 2015 | Jul 26, 2014 | Jul 27, 2013 | Jul 28, 2012 | Jul 30, 2011 | Jul 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||||||||
Net income | $ 13,267 | $ 10,180 | $ 10,320 | ||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
Depreciation, amortization, and other | 2,540 | 2,811 | 2,507 | ||||||||||||||
Depreciation, amortization and other | - | - | - | ||||||||||||||
Share-based compensation expense | 3,830 | 3,641 | 3,074 | ||||||||||||||
Provision for receivables | 23 | 24 | 34 | ||||||||||||||
Provision (benefit) for receivables | - | - | - | ||||||||||||||
Deferred income taxes | 226 | (1,133) | (972) | ||||||||||||||
Excess tax benefits from share-based compensation | - | - | - | ||||||||||||||
In-process research and development | - | - | - | ||||||||||||||
(Gains) losses on divestitures, investments and other, net | (1,358) | (38) | 215 | ||||||||||||||
Change in operating assets and liabilities, net of effects of acquisitions and divestitures: | |||||||||||||||||
Accounts receivable | (832) | (22) | (289) | ||||||||||||||
Inventories | (2,541) | 209 | 275 | ||||||||||||||
Financing receivables | (1,835) | 214 | 76 | ||||||||||||||
Other assets | (1,032) | (499) | (671) | ||||||||||||||
Lease receivables, net | - | - | - | ||||||||||||||
Accounts payable | 842 | 257 | (90) | ||||||||||||||
Income taxes, net | (2,304) | (1,839) | (4,539) | ||||||||||||||
Accrued compensation | 457 | (53) | (696) | ||||||||||||||
Deferred revenue | 1,125 | 248 | 1,220 | ||||||||||||||
Other liabilities | 1,769 | 193 | 416 | ||||||||||||||
Net cash provided by operating activities | 14,177 | 14,193 | 10,880 | ||||||||||||||
Cash flows from investing activities: | |||||||||||||||||
Purchases of investments | (8,974) | (4,589) | (4,230) | ||||||||||||||
Proceeds from sales of investments | 2,013 | 2,643 | 4,136 | ||||||||||||||
Proceeds from maturities of investments | 6,105 | 4,943 | 6,367 | ||||||||||||||
Acquisitions, net of cash and cash equivalents acquired and divestitures | (516) | (291) | (25,994) | ||||||||||||||
Acquisitions, net of cash and cash equivalents acquired and divestitures | - | - | - | ||||||||||||||
Acquisitions and divestitures | - | - | - | ||||||||||||||
Proceeds from business divestitures | - | - | - | ||||||||||||||
Proceeds from business divestiture | - | - | - | ||||||||||||||
Purchases of non-marketable equity securities | (946) | (383) | (284) | ||||||||||||||
Return of investments in non-marketable equity securities | 270 | 306 | 202 | ||||||||||||||
Acquisition of property and equipment | (1,410) | (905) | (670) | ||||||||||||||
Proceeds from sales of property and equipment | - | - | - | ||||||||||||||
Change in investments in privately held companies | - | - | - | ||||||||||||||
Other | (26) | 9 | (5) | ||||||||||||||
Net cash provided by (used in) investing activities | (3,484) | 1,733 | (20,478) | ||||||||||||||
Cash flows from financing activities: | |||||||||||||||||
Issuances of common stock | 805 | 736 | 714 | ||||||||||||||
Repurchases of common stock - repurchase program | (6,106) | (6,000) | (5,787) | ||||||||||||||
Shares repurchased for tax withholdings on vesting of restricted stock units | (1,873) | (1,222) | (992) | ||||||||||||||
Short-term borrowings, original maturities of 90 days or less, net | 616 | (31) | 478 | ||||||||||||||
Short-term borrowings, original maturities of 90 days or less, net | - | - | - | ||||||||||||||
Issuances of debt | 13,048 | 19,292 | 31,818 | ||||||||||||||
Repayments of debt | (12,251) | (22,073) | (9,826) | ||||||||||||||
Repayments of Splunk convertible debt, net of capped call proceeds | 0 | 0 | (3,140) | ||||||||||||||
Settlements of interest rate derivatives related to long-term debt | - | - | - | ||||||||||||||
Excess tax benefits from share-based compensation | - | - | - | ||||||||||||||
Dividends paid | (6,553) | (6,437) | (6,384) | ||||||||||||||
Other | (33) | (80) | (37) | ||||||||||||||
Net cash provided by (used in) financing activities | (12,347) | (15,815) | 6,844 | ||||||||||||||
Effect of foreign currency exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents | (29) | (43) | (31) | ||||||||||||||
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | (1,683) | 68 | (2,785) | ||||||||||||||
Net (decrease) increase in cash and cash equivalents | - | - | - | ||||||||||||||
Supplemental cash flow information: | |||||||||||||||||
Cash paid for interest | - | 1,500 | 583 | ||||||||||||||
Cash paid for income taxes, net | - | $ 3,892 | $ 7,426 |